Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hyperfine, Inc. (HYPR)
USD1.04
-0.01 (-0.48%)
US NASDAQ Healthcare Medical - Specialties
Address
351 New Whitfield Street 6437
Guilford, CT, US
Guilford, CT, US
CEO
Maria Degois Sainz
Website
hyperfinemri.com
IPO
2021-01-28
CIK 1833769 ISIN US44916K1060
Description
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| HealthCor Catalio Acquisition Corp. | HCAQ | 2021-08-30 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.04
-0.01 (-0.48%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
882.2K
Beta
1.39
Float Shares
64.57M
Free Float %
79.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.09% | -5.92% | +28.23% | +43.24% | +51.43% | +62.36% | +127.18% | +13.57% | -83.86% | -84.12% | -84.12% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
1.04
Low
1.60
+54.6%
Consensus
1.60
+54.6%
Median
1.60
+54.6%
High
1.60
+54.6%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 2 |
2.00
+93.2%
|
Quality scores
Altman Z-Score
-5.67
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%+5.2% Q1'26: +82.6% (vs Q1'25)
-
EPS growth Medical - Specialties: +10.1%+23.2% ★ Q1'26: +25.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%-233.4% Q1'26: -237.0% (vs Q1'25)
-
EBIT margin Medical - Specialties: +12.6%-273.4% Q1'26: -219.3% (vs Q1'25)
-
ROIC Medical - Specialties: +6.6%-594.9% Q1'26: +533.5% (vs Q1'25)
-
Share dilution Medical - Specialties: 0.0%+30.1% Q1'26: +29.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-0.01× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
6.81M
est: 7.69M (-11.4%)
|
11.03M
est: 11.94M (-7.6%)
|
12.89M
est: 13.86M (-7.0%)
|
13.56M
est: 13.39M (+1.3%)
|
20.02M
19.93M – 20.11M
+49.5% YoY
|
26.29M
26.04M – 26.55M
+31.3% YoY
|
34.88M
34.84M – 34.92M
+32.7% YoY
|
29.40M
29.27M – 29.53M
-15.7% YoY
|
| EBITDA |
-72.86M
est: -7.69M (-847.7%)
|
-47.06M
est: -11.94M (-294.1%)
|
-42.22M
est: -13.86M (-204.6%)
|
-34.88M
est: -13.39M (-160.5%)
|
-20.02M
-20.11M – -19.93M
-49.5% YoY
|
-26.29M
-26.55M – -26.04M
-31.3% YoY
|
-34.88M
-34.92M – -34.84M
-32.7% YoY
|
-29.40M
-29.53M – -29.27M
+15.7% YoY
|
| EBIT |
-73.87M
est: -7.69M (-860.9%)
|
-48.12M
est: -11.94M (-302.9%)
|
-43.22M
est: -13.86M (-211.9%)
|
-37.09M
est: -13.39M (-177.0%)
|
-20.02M
-20.11M – -19.93M
-49.5% YoY
|
-26.29M
-26.55M – -26.04M
-31.3% YoY
|
-34.88M
-34.92M – -34.84M
-32.7% YoY
|
-29.40M
-29.53M – -29.27M
+15.7% YoY
|
| Net Income |
-73.16M
est: -77.81M (+6.0%)
|
-44.24M
est: -54.38M (+18.7%)
|
-40.72M
est: -52.76M (+22.8%)
|
-35.57M
est: -42.86M (+17.0%)
|
-32.66M
-32.85M – -32.47M
+23.8% YoY
|
-31.09M
-31.27M – -30.91M
+4.8% YoY
|
-29.20M
-29.38M – -29.03M
+6.1% YoY
|
-27.32M
-27.48M – -27.16M
+6.5% YoY
|
| SGA |
46.63M
est: 100.88M (-53.8%)
|
30.38M
est: 92.94M (-67.3%)
|
26.62M
est: 107.87M (-75.3%)
|
26.39M
est: 104.21M (-74.7%)
|
155.80M
155.10M – 156.50M
+49.5% YoY
|
204.61M
202.63M – 206.60M
+31.3% YoY
|
271.48M
271.16M – 271.80M
+32.7% YoY
|
228.81M
227.78M – 229.85M
-15.7% YoY
|
| EPS |
-1.04
est: -1.07 (+3.2%)
|
-0.62
est: -0.58 (-7.4%)
|
-0.56
est: -0.56 (+0.0%)
|
-0.43
est: -0.46 (+5.5%)
|
-0.35
-0.35 – -0.34
+23.8% YoY
|
-0.33
-0.33 – -0.33
+4.8% YoY
|
-0.31
-0.31 – -0.31
+6.1% YoY
|
-0.29
-0.29 – -0.29
+6.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-28.87M
OE per share TTM
-0.36
Owner's Yield
-18.59%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
39.2%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
24
Total invested
6.89M
Insider transactions (90d)
0
Beneficial owners (>5%)
13
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 4C Holdings I, LLC | 14.24M | 94.56% | — | 14.24M | — | 10.00 | OO | Delaware | 2021-12-30 | ↗ |
| 2 | Arthur Bruce Cohen | 6.53M | 11.80% | — | 6.53M | — | 6.53M | IN | — | 2022-02-14 | ↗ |
| 3 | HC Sponsor LLC | 6.53M | 11.80% | — | 6.53M | — | 6.53M | OO | — | 2022-02-14 | ↗ |
| 4 | HealthCor Group, LLC | 6.53M | 11.80% | — | 6.53M | — | 6.53M | OO | New York | 2022-02-14 | ↗ |
| 5 | Joseph Patrick Healey | 6.53M | 11.80% | — | 6.53M | — | 6.53M | IN | — | 2022-02-14 | ↗ |
| 6 | The Vanguard Group - 23-1945930 | 3.18M | 5.62% | — | — | 3.16M | — | IA | Pennsylvania | 2024-02-13 | ↗ |
| 7 | Jonathan M. Rothberg, Ph.D. | 2.21M | 3.95% | 1.67M | 535.8K | 1.67M | 535.8K | IN | United States of America | 2021-12-30 | ↗ |
| 8 | 4C Holdings V, LLC | 818.8K | 5.44% | — | 818.8K | — | 11.00 | OO | — | 2021-12-30 | ↗ |
| 9 | 2012 JMR Trust Common, LLC | 585.7K | 1.07% | — | 585.7K | — | 11.00 | OO | — | 2021-12-30 | ↗ |
| 10 | 23rd Century Capital LLC | 440.3K | 1.00% | — | 440.3K | — | 440.3K | OO | Delaware | 2021-12-30 | ↗ |
| 11 | Amos Meron | — | 0.00% | — | — | — | — | IN | United States | 2022-02-10 | ↗ |
| 12 | Empyrean Capital Overseas Master Fund, Ltd. | — | 0.00% | — | — | — | — | CO | Cayman Islands | 2022-02-10 | ↗ |
| 13 | Empyrean Capital Partners, LP | — | 0.00% | — | — | — | — | PN | Delaware | 2022-02-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
24
-30 vs prev Q
New positions
5
Closed positions
33
Increased
8
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | EP WEALTH ADVISORS, LLC | 34.7K +34.7K (+100.0%) | 34.01M +34.0M (+100.0%) | 0.04% +0.044 pp | 0.00% +0.000 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 2 | VANGUARD GROUP INC | 3.57M +56.1K (+1.6%) | 3.49M -1.6M (-31.4%) | 4.51% +0.017 pp | 0.00% +0.000 pp | USD2.21 -55.7% | 16 qtrs — |
| 3 | SIO CAPITAL MANAGEMENT, LLC | 2.00M +2.0M (+100.0%) | 1.96M +2.0M (+100.0%) | 2.53% +2.531 pp | 0.31% +0.308 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 4 | FOSUN INTERNATIONAL LTD | 1.74M +— (+0.0%) | 1.71M -820.0K (-32.5%) | 2.20% -0.027 pp | 0.40% -0.547 pp | USD7.25 -86.5% | 17 qtrs — |
| 5 | NORTHERN TRUST CORP | 1.34M +227.2K (+20.4%) | 1.31M -302.6K (-18.7%) | 1.70% +0.270 pp | 0.00% +0.000 pp | USD0.94 +4.3% | 16 qtrs — |
| 6 | CATALIO CAPITAL MANAGEMENT, LP | 1.32M +635.5K (+92.8%) | 1.29M +300.1K (+30.2%) | 1.67% +0.794 pp | 0.23% +0.045 pp | USD0.93 +5.4% | 5 qtrs — |
| 7 | ALPHABET INC. | 898.7K +— (+0.0%) | 880.7K -422.4K (-32.4%) | 1.14% -0.014 pp | 0.03% -0.020 pp | USD7.25 -86.5% | 17 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 816.0K +144.0K (+21.4%) | 799.4K -175.5K (-18.0%) | 1.03% +0.172 pp | 0.00% +0.000 pp | USD1.77 -44.6% | 17 qtrs — |
| 9 | BLACKROCK, INC. | 574.9K -770.0 (-0.1%) | 563.0K -271.7K (-32.6%) | 0.73% -0.010 pp | 0.00% +0.000 pp | USD1.08 -9.3% | 6 qtrs — |
| 10 | JANE STREET GROUP, LLC | 482.5K +357.7K (+286.8%) | 472.5K +291.6K (+161.3%) | 0.61% +0.451 pp | 0.00% +0.000 pp | USD1.10 -10.9% | 2 qtrs — |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 364.7K +317.6K (+674.4%) | 357.2K +288.9K (+423.0%) | 0.46% +0.401 pp | 0.00% +0.001 pp | USD0.96 +2.1% | 9 qtrs — |
| 12 | ISTHMUS PARTNERS, LLC | 313.4K +— (+0.0%) | 306.9K -147.5K (-32.5%) | 0.40% -0.005 pp | 0.03% -0.067 pp | USD7.25 -86.5% | 17 qtrs — |
| 13 | STATE STREET CORP | 265.2K +15.2K (+6.1%) | 259.7K -102.8K (-28.4%) | 0.34% +0.015 pp | 0.00% +0.000 pp | USD2.31 -57.6% | 16 qtrs — |
| 14 | BANK OF AMERICA CORP /DE/ | 237.9K +237.3K (+40,991.0%) | 232.9K +232.1K (+27,661.7%) | 0.30% +0.300 pp | 0.00% +0.000 pp | USD0.98 +0.0% | 9 qtrs — |
| 15 | WALLEYE CAPITAL LLC | 216.7K +216.7K (+100.0%) | 212.2K +212.2K (+100.0%) | 0.27% +0.274 pp | 0.00% +0.001 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 16 | JOURNEY STRATEGIC WEALTH LLC | 186.7K +— (+0.0%) | 182.9K -87.9K (-32.5%) | 0.24% -0.003 pp | 0.00% -0.003 pp | USD1.03 -4.9% | 9 qtrs — |
| 17 | BANK OF NEW YORK MELLON CORP | 171.5K +— (+0.0%) | 167.9K -80.7K (-32.5%) | 0.22% -0.003 pp | 0.00% +0.000 pp | USD2.09 -53.1% | 16 qtrs — |
| 18 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119.7K +40.0K (+50.2%) | 117.2K +1.7K (+1.4%) | 0.15% +0.049 pp | 0.00% +0.000 pp | USD1.57 -37.6% | 15 qtrs — |
| 19 | XTX TOPCO LTD | 80.7K +26.2K (+47.9%) | 79.1K -63.0 (-0.1%) | 0.10% +0.032 pp | 0.00% -0.002 pp | USD1.30 -24.6% | 2 qtrs — |
| 20 | TORTOISE INVESTMENT MANAGEMENT, LLC | 72.0K +27.0K (+60.0%) | 70.5K +5.3K (+8.1%) | 0.09% +0.034 pp | 0.01% +0.000 pp | USD1.27 -22.8% | 2 qtrs — |
| 21 | CERITY PARTNERS LLC | 60.0K +60.0K (+100.0%) | 58.8K +58.8K (+100.0%) | 0.08% +0.076 pp | 0.00% +0.000 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 22 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 56.6K +— (+0.0%) | 57.8K -39.6K (-40.7%) | 0.07% -0.001 pp | 0.00% 0.000 pp | USD1.59 -38.4% | 10 qtrs — |
| 23 | MILLENNIUM MANAGEMENT LLC | 56.3K +56.3K (+100.0%) | 55.1K +55.1K (+100.0%) | 0.07% +0.071 pp | 0.00% +0.000 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 24 | KATHMERE CAPITAL MANAGEMENT, LLC | 51.8K +51.8K (+100.0%) | 50.7K +50.7K (+100.0%) | 0.07% +0.066 pp | 0.00% +0.003 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 25 | SIGNATUREFD, LLC | 49.1K +— (+0.0%) | 48.1K -23.1K (-32.5%) | 0.06% -0.001 pp | 0.00% 0.000 pp | USD2.05 -52.2% | 10 qtrs — |
| 26 | GSA CAPITAL PARTNERS LLP | 49.4K +49.4K (+100.0%) | 48.0K +48.0K (+100.0%) | 0.06% +0.063 pp | 0.00% +0.004 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 27 | PROCYON ADVISORS, LLC | 47.8K +— (+0.0%) | 46.8K -22.5K (-32.5%) | 0.06% -0.001 pp | 0.00% -0.002 pp | USD3.54 -72.3% | 16 qtrs — |
| 28 | ESSENTIAL PLANNING, LLC. | 42.4K +— (+0.0%) | 41.5K -20.0K (-32.5%) | 0.05% -0.001 pp | 0.01% -0.008 pp | USD0.72 +36.1% | 4 qtrs — |
| 29 | SANCTUARY ADVISORS, LLC | 39.9K +22.6K (+130.9%) | 39.1K +14.0K (+55.9%) | 0.05% +0.028 pp | 0.00% +0.000 pp | USD1.18 -16.9% | 2 qtrs — |
| 30 | UBS GROUP AG | 35.6K +32.8K (+1,152.7%) | 34.9K +30.7K (+746.0%) | 0.05% +0.041 pp | 0.00% +0.000 pp | USD0.97 +1.0% | 17 qtrs — |
| 31 | CITADEL ADVISORS LLC | 30.1K +3.7K (+14.0%) | 29.5K -8.8K (-23.0%) | 0.04% +0.004 pp | 0.00% +0.000 pp | USD1.39 -29.5% | 8 qtrs — |
| 32 | PARALLEL ADVISORS, LLC | 27.3K +— (+0.0%) | 26.8K -12.9K (-32.5%) | 0.03% 0.000 pp | 0.00% 0.000 pp | USD7.25 -86.5% | 17 qtrs — |
| 33 | LPL FINANCIAL LLC | 26.8K +8.4K (+45.3%) | 26.2K -508.0 (-1.9%) | 0.03% +0.010 pp | 0.00% +0.000 pp | USD1.09 -10.1% | 6 qtrs — |
| 34 | KNOLLWOOD INVESTMENT ADVISORY, LLC | 20.0K +— (+0.0%) | 19.6K -9.4K (-32.5%) | 0.03% 0.000 pp | 0.00% -0.001 pp | USD0.84 +16.7% | 13 qtrs — |
| 35 | COMMONWEALTH EQUITY SERVICES, LLC | 19.9K -500.0 (-2.4%) | 19.5K -10.5K (-35.0%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD1.13 -13.3% | 5 qtrs — |
| 36 | VIRTU FINANCIAL LLC | 18.7K +18.7K (+100.0%) | 18.0K +18.0K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.001 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 37 | MORGAN STANLEY | 12.0K +12.0K (+100.0%) | 11.8K +11.8K (+100.0%) | 0.02% +0.015 pp | 0.00% +0.000 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 38 | ADVISOR GROUP HOLDINGS, INC. | 11.9K +561.0 (+5.0%) | 11.6K -3.5K (-23.1%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD1.09 -10.1% | 17 qtrs — |
| 39 | UNIVEST FINANCIAL CORP | 10.8K +— (+0.0%) | 10.5K -5.1K (-32.5%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD0.72 +36.1% | 4 qtrs — |
| 40 | GUIDANCE POINT ADVISORS, LLC | 10.6K +— (+0.0%) | 10.4K -5.0K (-32.5%) | 0.01% 0.000 pp | 0.00% -0.001 pp | USD3.54 -72.3% | 16 qtrs — |
| 41 | 49 WEALTH MANAGEMENT, LLC | 10.0K +10.0K (+100.0%) | 9.8K +9.8K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.001 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 42 | TOWER RESEARCH CAPITAL LLC (TRC) | 8.6K +3.0K (+55.1%) | 8.4K +381.0 (+4.8%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD1.28 -23.4% | 15 qtrs — |
| 43 | GLOBAL RETIREMENT PARTNERS, LLC | 8.5K +— (+0.0%) | 8.3K -4.0K (-32.5%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD0.72 +36.1% | 3 qtrs — |
| 44 | JPMORGAN CHASE & CO | 6.5K +— (+0.0%) | 6.4K -3.1K (-32.5%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD1.45 -32.4% | 16 qtrs — |
| 45 | CAZ INVESTMENTS LP | 5.0K +— (+0.0%) | 4.9K -2.4K (-32.5%) | 0.01% 0.000 pp | 0.01% -0.005 pp | USD0.84 +16.7% | 13 qtrs — |
| 46 | WELLS FARGO & COMPANY/MN | 2.6K +— (+0.0%) | 2.5K -1.2K (-32.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.88 +11.4% | 5 qtrs — |
| 47 | BIRCHBROOK, INC. | 2.5K +— (+0.0%) | 2.4K -1.2K (-32.4%) | 0.00% +0.000 pp | 0.00% -0.001 pp | USD0.96 +2.1% | 9 qtrs — |
| 48 | SIMPLEX TRADING, LLC | 1.8K +1.8K (+100.0%) | 1.7K +1.7K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD0.98 +0.0% | 3 qtrs — |
| 49 | GROUP ONE TRADING, L.P. | 1.4K -111.0 (-7.4%) | 1.4K -815.0 (-37.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.72 +36.1% | 10 qtrs — |
| 50 | MTM INVESTMENT MANAGEMENT, LLC | 500.00 +— (+0.0%) | 490.00 -235.0 (-32.4%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD0.72 +36.1% | 3 qtrs — |
| 51 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 200.00 -21.5K (-99.1%) | 196.00 -31.3K (-99.4%) | 0.00% -0.028 pp | 0.00% 0.000 pp | USD1.45 -32.4% | 2 qtrs — |
| 52 | TWO SIGMA SECURITIES, LLC | — -19.8K (-100.0%) | — -28.7K (-100.0%) | 0.00% -0.025 pp | 0.00% -0.004 pp | USD— | 3 qtrs SOLD |
| 53 | CITIGROUP INC | — -1.0 (-100.0%) | — -1.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 54 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | — -42.6K (-100.0%) | — -61.8K (-100.0%) | 0.00% -0.055 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 55 | ROYAL BANK OF CANADA | — -31.2K (-100.0%) | — -45.0K (-100.0%) | 0.00% -0.040 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 56 | BARCLAYS PLC | — -45.0K (-100.0%) | — -48.6K (-100.0%) | 0.00% -0.058 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 33 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.02% | 285.4K | 0.60% |
| 2 | iShares Russell 2000 Growth ETF IWO | 0.01% | 803.4K | 0.24% |
| 3 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.00% | 102.3K | 0.30% |
| 4 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.00% | 8.7K | 0.25% |
| 5 | Global X - Russell 2000 ETF RSSL | 0.00% | 39.9K | 0.08% |
| 6 | iShares Russell 2000 BuyWrite ETF IWMW | 0.00% | 1.3K | 0.39% |
| 7 | iShares Russell 2000 ETF IWM | 0.00% | 1.88M | 0.19% |
| 8 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.00% | 12.2K | 0.36% |
| 9 | Vanguard Extended Market ETF VXF | 0.00% | 1.43M | 0.05% |
| 10 | ProShares - Ultra Russell2000 UWM | 0.00% | 3.4K | 1.07% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
3
Sells
3
Shares acquired
1.41M
Shares disposed
49.2K
Cash buys
—
Cash sales
3.00
Net activity
+1,360,803
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | TEISSEYRE THOMAS | Officer | A-Award | A | Class A Common Stock | 330,000 | 0.00 | — | 684,648 | D | ↗ |
| 2026-03-31 | Sainz Maria | Director / Officer | A-Award | A | Class A Common Stock | 750,000 | 0.00 | — | 789,586 | D | ↗ |
| 2026-03-31 | HALE BRETT | Officer | A-Award | A | Class A Common Stock | 330,000 | 0.00 | — | 605,812 | D | ↗ |
| 2026-03-23 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 24,188 | 1.21 | 29.3K | 354,648 | D | ↗ |
| 2026-03-23 | HALE BRETT | Officer | S-Sale | D | Class A Common Stock | 24,188 | 1.21 | 29.3K | 275,812 | D | ↗ |
| 2026-02-13 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 821 | 1.11 | 912.54 | 378,836 | D | ↗ |
| 2025-11-19 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 1,405 | 1.08 | 1.5K | 379,657 | D | ↗ |
| 2025-08-18 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 1,151 | 1.33 | 1.5K | 381,062 | D | ↗ |
| 2025-06-05 | Wolterman Dan | Director | A-Award | A | Stock Options (right to buy) | 81,817 | 0.86 | 70.6K | 81,817 | D | ↗ |
| 2025-05-20 | Wolterman Dan | Director | A-Award | A | Stock Options (right to buy) | 79,200 | 0.62 | 49.3K | 79,200 | D | ↗ |
| 2025-05-20 | Fattori Ruth A | Director | A-Award | A | Stock Options (right to buy) | 79,200 | 0.62 | 49.3K | 79,200 | D | ↗ |
| 2025-05-20 | Dahldorf John T | Director | A-Award | A | Stock Options (right to buy) | 79,200 | 0.62 | 49.3K | 79,200 | D | ↗ |
| 2025-05-16 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 2,776 | 0.58 | 1.6K | 82,213 | D | ↗ |
| 2025-03-31 | TEISSEYRE THOMAS | Officer | A-Award | A | Class A Common Stock | 300,000 | 0.00 | — | 382,213 | D | ↗ |
| 2025-03-31 | HALE BRETT | Officer | A-Award | A | Class A Common Stock | 300,000 | 0.00 | — | 300,000 | D | ↗ |
| 2025-02-20 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 3,238 | 1.08 | 3.5K | 84,989 | D | ↗ |
| 2025-02-18 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 3,237 | 1.20 | 3.9K | 84,990 | D | ↗ |
| 2024-11-18 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 2,800 | 0.85 | 2.4K | 88,227 | D | ↗ |
| 2024-08-16 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 2,746 | 1.05 | 2.9K | 91,027 | — | ↗ |
| 2024-06-12 | Wolterman Dan | Director | A-Award | A | Stock Options (right to buy) | 79,200 | 0.87 | 68.9K | 79,200 | — | ↗ |
| 2024-06-12 | ROTHBERG JONATHAN M | Director / 10% Owner | A-Award | A | Stock Options (right to buy) | 79,200 | 0.87 | 68.9K | 79,200 | — | ↗ |
| 2024-06-12 | Huennekens R Scott | Director | A-Award | A | Stock Options (right to buy) | 79,200 | 0.87 | 68.9K | 79,200 | — | ↗ |
| 2024-06-12 | Fattori Ruth A | Director | A-Award | A | Stock Options (right to buy) | 79,200 | 0.87 | 68.9K | 79,200 | — | ↗ |
| 2024-06-12 | Dahldorf John T | Director | A-Award | A | Stock Options (right to buy) | 79,200 | 0.87 | 68.9K | 79,200 | — | ↗ |
| 2024-05-16 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 2,753 | 0.88 | 2.4K | 93,773 | — | ↗ |
| 2024-03-28 | TEISSEYRE THOMAS | Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 1.00 | 500.0K | 500,000 | — | ↗ |
| 2024-03-28 | Sainz Maria | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,435,000 | 1.00 | 1.44M | 1,435,000 | — | ↗ |
| 2024-03-28 | HALE BRETT | Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 1.00 | 500.0K | 500,000 | — | ↗ |
| 2024-02-16 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 3,230 | 1.11 | 3.6K | 96,526 | — | ↗ |
| 2023-11-16 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 2,655 | 1.26 | 3.3K | 99,756 | — | ↗ |
| 2023-08-16 | TEISSEYRE THOMAS | Officer | S-Sale | D | Class A Common Stock | 2,785 | 2.26 | 6.3K | 102,411 | — | ↗ |
| 2023-08-16 | Siddiqui Khan | Officer | S-Sale | D | Class A Common Stock | 1,729 | 2.26 | 3.9K | 76,981 | — | ↗ |
| 2023-07-24 | TEISSEYRE THOMAS | Officer | — | — | Class A Common Stock | 0 | 0.00 | — | 105,196 | D | ↗ |
| 2023-06-09 | Wolterman Dan | Director | A-Award | A | Stock Options (right to buy) | 85,000 | 1.97 | 167.5K | 85,000 | D | ↗ |
| 2023-06-09 | ROTHBERG JONATHAN M | Director / 10% Owner | A-Award | A | Stock Options (right to buy) | 112,000 | 1.97 | 220.6K | 112,000 | — | ↗ |
| 2023-06-09 | Huennekens R Scott | Director | D-Return | D | Stock Options (right to buy) | 237,437 | 0.91 | 216.1K | 0 | — | ↗ |
| 2023-06-09 | Fattori Ruth A | Director | A-Award | A | Stock Options (right to buy) | 85,000 | 1.97 | 167.5K | 85,000 | — | ↗ |
| 2023-06-09 | Dahldorf John T | Director | A-Award | A | Stock Options (right to buy) | 85,000 | 1.97 | 167.5K | 85,000 | — | ↗ |
| 2023-05-23 | Siddiqui Khan | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 1.40 | 140.0K | 100,000 | — | ↗ |
| 2023-05-16 | Siddiqui Khan | Officer | S-Sale | D | Class A Common Stock | 1,735 | 1.25 | 2.2K | 78,710 | — | ↗ |
| 2023-03-03 | Siddiqui Khan | Officer | A-Award | A | Stock Option (right to buy) | 368,400 | 1.52 | 560.0K | 368,400 | — | ↗ |
| 2023-02-16 | Siddiqui Khan | Officer | S-Sale | D | Class A Common Stock | 4,635 | 1.39 | 6.4K | 80,445 | — | ↗ |
| 2023-02-16 | Gupta Alok | Officer | S-Sale | D | Class A Common Stock | 5,613 | 1.39 | 7.8K | 110,456 | — | ↗ |
| 2023-02-13 | HALE BRETT | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-16 | HC Sponsor LLC | Director | J-Other | D | Class A Common Stock | 5,534,000 | 0.00 | — | 0 | — | ↗ |
| 2022-12-14 | Sainz Maria | Officer | P-Purchase | A | Class A Common Stock | 5,000 | 0.95 | 4.8K | 39,425 | — | ↗ |
| 2022-12-09 | Sainz Maria | Officer | P-Purchase | A | Class A Common Stock | 12,425 | 0.85 | 10.6K | 34,425 | — | ↗ |
| 2022-12-08 | Sainz Maria | Officer | P-Purchase | A | Class A Common Stock | 2,575 | 0.83 | 2.1K | 22,161 | — | ↗ |
| 2022-11-30 | ROTHBERG JONATHAN M | Director | P-Purchase | A | Class A Common Stock | 229,215 | 0.82 | 188.0K | 885,707 | — | ↗ |
| 2022-11-29 | ROTHBERG JONATHAN M | Director | P-Purchase | A | Class A Common Stock | 47,007 | 0.72 | 33.8K | 656,492 | — | ↗ |
| 2022-11-16 | Siddiqui Khan | Officer | S-Sale | D | Class A Common Stock | 1,039 | 84.00 | 87.3K | 85,080 | — | ↗ |
| 2022-11-16 | Paykel Neela | Officer | S-Sale | D | Common Stock | 1,895 | 0.84 | 1.6K | 113,172 | — | ↗ |
| 2022-11-16 | Gupta Alok | Officer | S-Sale | D | Class A Common Stock | 2,227 | 0.84 | 1.9K | 116,069 | — | ↗ |
| 2022-11-15 | ROTHBERG JONATHAN M | Director | P-Purchase | A | Class A Common Stock | 31,139 | 0.92 | 28.6K | 609,485 | — | ↗ |
| 2022-11-14 | ROTHBERG JONATHAN M | Director | P-Purchase | A | Class A Common Stock | 34,488 | 0.89 | 30.7K | 578,346 | — | ↗ |
| 2022-10-31 | Siddiqui Khan | Officer | D-Return | D | Stock Option (right to buy) | 74,000 | 0.00 | — | 0 | — | ↗ |
| 2022-10-31 | Sainz Maria | Officer | A-Award | A | Stock Option (right to buy) | 3,175,000 | 0.00 | — | 3,175,000 | — | ↗ |
| 2022-10-31 | Paykel Neela | Officer | D-Return | D | Stock Option (right to buy) | 98,250 | 0.00 | — | 0 | — | ↗ |
| 2022-10-31 | Huennekens R Scott | Director | D-Return | D | Stock Option (right to buy) | 237,437 | 0.00 | — | 0 | — | ↗ |
| 2022-10-31 | Gupta Alok | Officer | D-Return | D | Stock Option (right to buy) | 54,333 | 0.00 | — | 0 | — | ↗ |
| 2022-10-31 | Fattori Ruth A | Director | D-Return | D | Stock Option (right to buy) | 100,000 | 0.00 | — | 0 | — | ↗ |
| 2022-08-16 | ROTHBERG JONATHAN M | Director | P-Purchase | A | Class A Common Stock | 64,213 | 1.48 | 95.2K | 543,858 | — | ↗ |
| 2022-08-15 | Siddiqui Khan | Officer | S-Sale | D | Class A Common Stock | 1,035 | 1.45 | 1.5K | 86,119 | — | ↗ |
| 2022-08-15 | Paykel Neela | Officer | S-Sale | D | Common Stock | 1,891 | 1.45 | 2.7K | 115,067 | — | ↗ |
| 2022-08-15 | Gupta Alok | Officer | S-Sale | D | Class A Common Stock | 8,871 | 1.45 | 12.9K | 118,296 | — | ↗ |
| 2022-08-12 | ROTHBERG JONATHAN M | Director | P-Purchase | A | Class A Common Stock | 303,137 | 1.46 | 441.7K | 479,645 | — | ↗ |
| 2022-07-05 | Siddiqui Khan | Officer | S-Sale | D | Class A Common Stock | 4,846 | 2.02 | 9.8K | 87,154 | — | ↗ |
| 2022-07-05 | Paykel Neela | Officer | S-Sale | D | Common Stock | 10,542 | 2.02 | 21.3K | 116,958 | — | ↗ |
| 2022-06-14 | ROTHBERG JONATHAN M | Director | P-Purchase | A | Class A Common Stock | 52,848 | 2.26 | 119.4K | 176,508 | — | ↗ |
| 2022-06-09 | Wolterman Dan | Director | A-Award | A | Stock Options (right to buy) | 85,345 | 0.00 | — | 85,345 | — | ↗ |
| 2022-06-09 | Sainz Maria | Director | A-Award | A | Stock Options (right to buy) | 85,345 | 0.00 | — | 85,345 | — | ↗ |
| 2022-06-09 | ROTHBERG JONATHAN M | Director | A-Award | A | Stock Options (right to buy) | 85,345 | 0.00 | — | 85,345 | — | ↗ |
| 2022-06-09 | Huennekens R Scott | Director | A-Award | A | Stock Options (right to buy) | 85,345 | 2.20 | 187.8K | 85,345 | — | ↗ |
| 2022-06-09 | Fattori Ruth A | Director | A-Award | A | Stock Options (right to buy) | 85,345 | 0.00 | — | 85,345 | — | ↗ |
| 2022-06-09 | Dahldorf John T | Director | A-Award | A | Stock Options (right to buy) | 85,345 | 0.00 | — | 85,345 | — | ↗ |
| 2022-04-26 | Scott David D | Officer | A-Award | A | Class A Common Stock | 649,350 | 0.00 | — | 799,350 | — | ↗ |
| 2022-03-29 | White Scott A. | Officer | A-Award | A | Class A Common Stock | 21,875 | 0.00 | — | 96,875 | — | ↗ |
| 2022-03-29 | Siddiqui Khan | Officer | A-Award | A | Class A Common Stock | 55,000 | 0.00 | — | 55,000 | — | ↗ |
| 2022-03-29 | Scott David D | Officer | A-Award | A | Stock Option (right to buy) | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2022-03-29 | Paykel Neela | Officer | A-Award | A | Class A Common Stock | 42,500 | 0.00 | — | 127,500 | — | ↗ |
| 2022-03-29 | Huennekens R Scott | Director | A-Award | A | Stock Option (right to buy) | 237,437 | 0.00 | — | 237,437 | — | ↗ |
| 2022-03-29 | Gupta Alok | Officer | A-Award | A | Class A Common Stock | 27,167 | 0.00 | — | 127,167 | — | ↗ |
| 2022-03-08 | Fattori Ruth A | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 3.15 | 315.0K | 100,000 | — | ↗ |
| 2022-02-09 | White Scott A. | Officer | A-Award | A | Stock Option (right to buy) | 43,750 | 0.00 | — | 43,750 | — | ↗ |
| 2022-02-09 | Siddiqui Khan | Officer | A-Award | A | Stock Option (right to buy) | 110,000 | 0.00 | — | 110,000 | — | ↗ |
| 2022-02-09 | Paykel Neela | Officer | A-Award | A | Stock Option (right to buy) | 85,000 | 0.00 | — | 85,000 | — | ↗ |
| 2022-02-09 | Hughes Mark A. | Officer | A-Award | A | Stock Option (right to buy) | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2022-02-09 | Gupta Alok | Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2022-02-03 | HC Sponsor LLC | Director | P-Purchase | A | Class A Common Stock | 21,947 | 4.00 | 87.8K | 1,250,000 | — | ↗ |
| 2022-01-26 | HC Sponsor LLC | Director | P-Purchase | A | Class A Common Stock | 78,053 | 3.75 | 292.5K | 1,228,053 | — | ↗ |
| 2022-01-21 | HC Sponsor LLC | Director | P-Purchase | A | Class A Common Stock | 25,000 | 4.50 | 112.6K | 1,150,000 | — | ↗ |
| 2022-01-12 | HC Sponsor LLC | Director | P-Purchase | A | Class A Common Stock | 8,410 | 6.57 | 55.2K | 1,125,000 | — | ↗ |
| 2022-01-11 | HC Sponsor LLC | Director | P-Purchase | A | Class A Common Stock | 2,913 | 6.73 | 19.6K | 1,116,590 | — | ↗ |
| 2022-01-10 | HC Sponsor LLC | Director | P-Purchase | A | Class A Common Stock | 13,677 | 6.70 | 91.6K | 1,113,677 | — | ↗ |
| 2021-12-29 | HC Sponsor LLC | Director | P-Purchase | A | Class A Common Stock | 100,000 | 7.00 | 700.0K | 1,100,000 | — | ↗ |
| 2021-12-23 | Wolterman Dan | Director | A-Award | A | Class A Common Stock | 16,483 | 0.00 | — | 16,483 | — | ↗ |
| 2021-12-23 | Sainz Maria | Director | A-Award | A | Class A Common Stock | 16,483 | 0.00 | — | 16,483 | — | ↗ |
| 2021-12-23 | ROTHBERG JONATHAN M | Director / 10% Owner | A-Award | A | Class A Common Stock | 19,586 | 0.00 | — | 123,660 | D | ↗ |
| 2021-12-23 | Huennekens R Scott | Director | A-Award | A | Class A Common Stock | 16,483 | 0.00 | — | 16,483 | D | ↗ |
| 2021-12-23 | Fattori Ruth A | Director | A-Award | A | Class A Common Stock | 16,483 | 0.00 | — | 17,374 | D | ↗ |
| 2021-12-23 | Dahldorf John T | Director | A-Award | A | Class A Common Stock | 19,586 | 0.00 | — | 19,586 | — | ↗ |
| 2021-12-22 | Wolterman Dan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | White Scott A. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | Siddiqui Khan | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | Scott David D | Officer | A-Award | A | Stock Option (right to buy) | 474,875 | 1.07 | 508.1K | 474,875 | — | ↗ |
| 2021-12-22 | Sainz Maria | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | ROTHBERG JONATHAN M | Director / 10% Owner | A-Award | A | Class A Common Stock | 95,507 | 0.00 | — | 95,507 | I | ↗ |
| 2021-12-22 | Paykel Neela | Officer | A-Award | A | Stock Option (right to buy) | 98,250 | 1.07 | 105.1K | 98,250 | — | ↗ |
| 2021-12-22 | Hughes Mark A. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | Huennekens R Scott | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | HC Sponsor LLC | Director | A-Award | A | Class A Common Stock | 1,000,000 | 0.00 | 100.00 | 6,534,000 | — | ↗ |
| 2021-12-22 | Gupta Alok | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | Fattori Ruth A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | Dahldorf John T | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-26 | Turnacioglu Kenan Kent | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-26 | Petrocheilos George C | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-26 | Horev Avi Daniel | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-26 | Gaulin Christopher Jon | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-26 | Clarke Christine | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-09-21 | SLEPICKA KENNETH J | Director | P-Purchase | A | Common Stock | 1,000 | 3.53 | 3.5K | 5,197 | — | ↗ |
| 2003-05-22 | SLEPICKA KENNETH J | Director | A-Award | A | Options | 3,333 | 0.64 | 2.1K | 28,333 | — | ↗ |
| 2003-05-15 | SLEPICKA KENNETH J | Director | A-Award | A | Options | 5,000 | 0.39 | 2.0K | 25,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-3.6K
Shares Outstanding
81.70M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Maria Sainz, President and Chief Executive Officer | 582.2K | — | — | — | 314.6K | — | 896.8K | 0.00% | ↗ |
| 2 | 2025 | Brett Hale, Chief Administrative Officer and Chief Financial Officer | 449.8K | — | 214.8K | — | 135.0K | — | 799.6K | 26.86% | ↗ |
| 3 | 2025 | Thomas Teisseyre, Ph.D., Chief Operating Officer | 449.8K | — | 214.8K | — | 135.0K | — | 799.6K | 26.86% | ↗ |
| 4 | 2024 | Maria Sainz, President and Chief Executive Officer | 567.7K | — | — | 1.44M | 266.5K | — | 2.27M | 63.24% | ↗ |
| 5 | 2024 | Thomas Teisseyre, Ph.D., Chief Operating Officer | 438.8K | — | — | 500.0K | 114.5K | — | 1.05M | 47.47% | ↗ |
| 6 | 2024 | Brett Hale, Chief Administrative Officer and Chief Financial Officer | 438.8K | — | — | 500.0K | 114.5K | — | 1.05M | 47.47% | ↗ |
| 7 | 2023 | Brett Hale, Chief Administrative Officer and Chief Financial Officer | 367.8K | 100.0K | — | 1.23M | 112.5K | — | 1.81M | 67.95% | ↗ |
| 8 | 2023 | Thomas Teisseyre, Ph.D., Chief Operating Officer | 410.1K | — | — | 554.0K | 109.1K | — | 1.07M | 51.62% | ↗ |
| 9 | 2023 | Maria Sainz, President and Chief Executive Officer | 550.0K | — | — | — | 297.0K | — | 847.0K | 0.00% | ↗ |
| 10 | 2022 | Maria Sainz, President and Chief Executive Officer | 95.2K | 125.0K | — | 3.08M | 65.5K | 154.6K | 3.52M | 87.48% | ↗ |
| 11 | 2022 | Dave Scott, Former President and Chief Executive Officer | 432.7K | — | — | 2.57M | — | 40.2K | 3.05M | 84.47% | ↗ |
| 12 | 2022 | Khan Siddiqui, M.D., Chief Medical Officer and Chief Strategy Officer | 407.1K | — | 92.0K | 860.1K | 147.0K | 27.9K | 1.53M | 62.06% | ↗ |
| 13 | 2022 | Scott White, Former Chief Commercial Officer | 283.8K | — | 312.9K | 813.8K | — | 85.4K | 1.50M | 75.32% | ↗ |
| 14 | 2022 | R. Scott Huennekens, Former Interim President and Chief Executive Officer | 112.3K | — | — | — | — | 1.28M | 1.39M | 0.00% | ↗ |
| 15 | 2022 | Alok Gupta, Former Chief Financial Officer and Treasurer | 392.3K | — | 127.2K | 76.3K | 112.0K | 26.6K | 734.4K | 27.71% | ↗ |
| 16 | 2021 | Dave Scott, Former President and Chief Executive Officer | 252.1K | 2.00M | 799.4K | 5.85M | — | — | 8.90M | 74.70% | ↗ |
| 17 | 2021 | Dave Scott, President and Chief Executive Officer | 252.1K | 2.00M | — | 5.85M | — | — | 8.10M | 72.20% | ↗ |
| 18 | 2021 | Neela Paykel, General Counsel, Chief Compliance Officer and Corporate Secretary | 233.3K | 152.5K | — | 201.7K | — | — | 587.5K | 34.33% | ↗ |
| 19 | 2021 | Khan Siddiqui, M.D., Chief Medical Officer and Chief Strategy Officer | 331.3K | 144.0K | — | 108.2K | — | — | 583.4K | 18.54% | ↗ |
| 20 | 2020 | Khan Siddiqui, M.D., Chief Medical Officer and Chief Strategy Officer | 255.2K | 150.0K | — | 494.2K | — | — | 899.4K | 54.95% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Maria Sainz | Chief Executive Officer, President & Director | 896.8K | female |
| Thomas Teisseyre | Chief Operating Officer | 799.6K | — |
| Brett Hale | Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer & Corporate Secretary | 799.6K | male |
| Jonathan Rothberg | Founder & Vice Chairman | 50.0K | — |
| Chip Truwit FACR | Senior Vice President of Office Strategy and Partnerships | — | male |
| Rafael Donnay | Senior Vice President of Hospital Business | — | — |
| Rafael O'Halloran | Vice President of Technology | — | — |
| Rob Fasciano | Chief Regulatory & Quality Officer | — | male |
| Edmond Knopp | Chief Medical Officer | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HYPR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
